Differentiation induction of human keratinocytes by phosphatidylethanolamine-binding protein

Takehiko Yamazaki1, Hajime Nakano, Makoto Hayakari

  • 1Second Department of Biochemistry, Hirosaki University School of Medicine, Hirosaki 036-8562, Japan.

Insights

Phosphatidylethanolamine-binding protein (PEBP) inhibits cell proliferation and promotes human keratinocyte differentiation. This protein is expressed in differentiated skin layers and cancers, and its induction enhances keratinocyte differentiation markers.

Area of Science:

  • Cell Biology
  • Dermatology
  • Molecular Biology

Background:

  • Phosphatidylethanolamine-binding protein (PEBP) is known to inhibit the extracellular signal-regulated kinase (ERK) pathway, suppressing cell proliferation.
  • The role of PEBP in the differentiation of human keratinocytes remains largely unexplored.

Purpose of the Study:

  • To investigate the involvement of PEBP in the differentiation induction of human keratinocytes.
  • To examine PEBP expression patterns in normal human skin and skin cancers.

Main Methods:

  • Immunohistochemistry was used to analyze PEBP expression in skin tissues.
  • Northern blotting and immunoblot analysis were performed on cultured keratinocytes treated with calcium chloride.
  • HaCaT keratinocytes were transfected with a PEBP expression vector to assess its functional effects.

Main Results:

  • PEBP expression was observed in differentiated epidermal layers and differentiated skin cancers, but not in basal cells or undifferentiated carcinomas.
  • Calcium treatment induced both PEBP and involucrin mRNA and protein levels in cultured keratinocytes.
  • Overexpression of PEBP in keratinocytes led to enlarged, flattened cell morphology, increased involucrin expression, decreased phosphorylated ERK levels, and partial inhibition of cell proliferation.

Conclusions:

  • PEBP plays a dual role in keratinocytes, inhibiting cell proliferation and inducing differentiation.
  • PEBP expression correlates with keratinocyte differentiation in vivo and in vitro.
  • PEBP may represent a novel therapeutic target for skin differentiation disorders.